US panel narrows recommendations for low dose aspirin for cardiovascular disease preventionBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h4991 (Published 21 September 2015) Cite this as: BMJ 2015;351:h4991
- Michael McCarthy
Adults aged 50 to 59 who are at risk of cardiovascular disease should take low dose aspirin for primary prevention, the US Preventive Services Task Force has concluded in draft recommendations released on 15 September.1 2 Previously, the task force had recommended aspirin for men aged 45 to 79 for the prevention of myocardial infarction and for women aged 55 to 79 for the prevention of ischemic stroke.
An independent panel of experts on prevention and evidence based medicine was commissioned by the US Agency for Healthcare Research and Quality to draft recommendations for clinical preventive services. The new recommendations apply to adults without known cardiovascular disease who do not have conditions that increase their risk of bleeding, such as gastrointestinal ulcers, or who use drugs that increase the risk of bleeding.
In the draft document the panel recommended low dose aspirin for the primary prevention of cardiovascular disease in adults aged 50 to 59 years …